Global Cardiovascular Monitoring and Diagnostic Devices Market- Restraints
The application complications in monitoring devices are expected to hamper the global cardiovascular monitoring and diagnostic devices market growth. For instance, according to an article published by the American Heart Association, Inc., on May 2, 2023, stated wearable devices have a wide range of potential clinical applications ranging from arrhythmia screening of high-risk individuals to remote management of chronic conditions such as heart failure or peripheral artery disease. As the use of wearable devices continues to grow, one must adopt a multifaceted approach with collaboration among all key stakeholders to effectively and safely integrate these technologies into routine clinical practice.
To counterbalance this restraint, simpler devices should be introduced.
Global Cardiovascular Monitoring and Diagnostic Devices Market- Market Drivers
Increasing inorganic strategies such as agreements among market players, and increasing acquisitions by key players is expected to drive the global cardiovascular monitoring and diagnostic devices market growth over the forecast period. For instance, on November 8, 2021, Royal Philips, a global company in health technology, announced that it has signed an agreement to acquire Cardiologs, a France-based medical technology company focused on transforming cardiac diagnostics using artificial intelligence (AI) and cloud technology. Cardiologs will further strengthen Philips’ cardiac monitoring and diagnostics offering with innovative software technology, electrocardiogram (ECG) analysis and reporting services.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients